(Q35001574)

5 August 2017

1 reference

title

Genetic alterations and signaling pathways in the evolution of gliomas (English)

1 reference

5 August 2017

Hiroko Ohgaki

1

1 reference

5 August 2017

Paul Kleihues

series ordinal

2

1 reference

5 August 2017

publication date

6 August 2009

1 reference

5 August 2017

1 reference

5 August 2017

volume

100

1 reference

5 August 2017

issue

12

1 reference

5 August 2017

page(s)

2235-2241

1 reference

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01308.X

Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01308.X

PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01308.X

Loss of heterozygosity on chromosome 19 in secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01308.X

The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01308.X

Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01308.X

10.1111/J.1349-7006.2009.01308.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference